logo

3.26

3.26 (-3.42%)

As of Jun 14, 2022

Kronos Bio, Inc. [KRON]

Source: 

Company Overview

Kronos Bio, Inc is an integrated discovery through clinical development biopharmaceutical company, with a focus on developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. We are enrolling patients in clinical trials for two compounds.

CountryUnited States
Headquarterssan mateocalifornia
Phone Number(650) 781-5200
Industry
manufacturing
CEONorbert Bischofberger
Websitewww.kronosbio.com

Related Stories